Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

NSE/NOVARTIND stock hub

NSE/NOVARTIND has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/NOVARTINDis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

27.5B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/NOVARTIND

In the news

Latest news · NSE/NOVARTIND

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 24.9P50 32.4P75 45.7

Trailing P/E28.3

P25 24.8P50 35.9P75 56.9

ROEn/a

P25 6.3P50 13.6P75 18.1

ROIC40.6

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/NOVARTIND market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

155

Groups with data

Currency

INR

Showing 155 of 155 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	56
Employees Change	-6%
Employees Change Percent	-9.68
Enterprise value	INR 21.3B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	INE234A01025
Last refreshed	2026-05-10
Market cap	INR 27.5B
Price	INR 1,115
Price currency	INR
Rev Per Employee	62,082,142.86x
Sector	Healthcare
Sic	2834
Symbol	nse/NOVARTIND
Website	https://www.novartis.in

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.54%
EV Earnings	21.95x
EV/EBIT	23.65x
EV/EBITDA	23.04x
EV/Sales	6.14x
P/B ratio	3.54x
P/E ratio	28.25x
P/S ratio	7.9x
PE Ratio10 Y	40.4x
PE Ratio3 Y	23.92x
PE Ratio5 Y	36.78x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	25.95%
EBITDA Margin	26.15%
Gross margin	43.77%
Gross Profit	INR 1.5B
Gross Profit Growth	6.4%
Gross Profit Growth Q	-13.02%
Gross Profit Growth3 Y	-8.07%
Gross Profit Growth5 Y	-8.48%
Net Income	INR 972.3M
Net Income Growth	12.69%
Net Income Growth Q	-36.78%
Net Income Growth Years	1%
Net Income Growth3 Y	20.94%
Net Income Growth5 Y	40.15%
Pretax Margin	38.37%
Profit Margin	27.97%
Profit Per Employee	INR 17.4M
Profitable Years	3
Roa5y	3.3
Roe5y	8.17
ROIC	40.63
Roic5y	20.52

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Div CAGR3	-19.26%
Div CAGR5	20.11%
EPS Growth	12.69
EPS Growth Q	-36.76
EPS Growth Years	1
EPS Growth3 Y	20.93
EPS Growth5 Y	40.19
Revenue Growth	-1.67x
Revenue Growth Q	-7.63x
Revenue Growth Years	1x
Revenue Growth3 Y	-4.64x
Revenue Growth5 Y	-1.54x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 6.2B
Debt	INR 40.5M
Debt EBITDA	INR 0.04
Debt Equity	INR 0.01
Equity	INR 7.8B
Interest Coverage	68.87
Net Cash	INR 6.1B
Net Cash By Market Cap	INR 22.32
Net Cash Growth	3.73%
Net Debt EBITDA	INR -6.75
Net Debt Equity	INR -0.79
Tangible Book Value	INR 7.8B
Tangible Book Value Per Share	INR 314
WACC	6.61

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.01%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	INR 25
Dividend Years	6
Dividend Yield	2.41%
Ex Div Date	2025-07-23
Last Dividend	INR 25
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
All Time High	1,125
All Time High Change	-0.9%
All Time High Date	2026-05-08
All Time Low	950
All Time Low Change	17.36%
All Time Low Date	2026-04-24
ATR	37.56
Beta	0.43
High	1,125
High52	1,125
High52 Date	2026-05-08
High52ch	-0.21%
Low	1,060.2
Low52	950
Low52 Date	2026-04-24
Low52ch	17.36%
RSI	0
RSI Monthly	0
RSI Weekly	0
Sharpe ratio	5.53x
Sortino ratio	16.61
Total Return	2.4%
Tr1w	8.63%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 902.2M
Operating Income Growth	9.24
Operating Income Growth Q	-12.65
Operating Income Growth3 Y	13.08
Operating Income Growth5 Y	50.38
Operating margin	25.95

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	6,695,185%
Shares Insiders	0%
Shares Institutions	0.17%
Shares Qo Q	-0.05%
Shares Yo Y	0.01%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	12,909.21x
Bv Per Share	313.9
Ch1w	8.63
Change	4.56%
Change From Open	4.56
Close	1,066.3
Days Gap	0
Depreciation Amortization	6,875,000
Dollar Volume	30,143,551.3
EBIT	INR 902.2M
EBITDA	INR 909.1M
EPS	INR 39.38
F Score	2
Fiscal Year End	March
Founded	1,947
Graham Number	528.47399
Graham Upside	-52.6
Income Tax	INR 361.8M
Is Primary Listing	0
Last Report Date	2025-12-31
Lynch Fair Value	INR 987
Lynch Upside	-11.52
Open	1,066.3
Payment Date	2025-08-30
Position In Range	84.41
Price Date	2026-05-08
Price EBITDA	INR 30.22
Ptbv Ratio	3.54
Relative Volume	2.28x
Revenue	3,476,600,000x
Tax By Revenue	10.41x
Tax Rate	27.12%
Volume	27,037

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

NSE/NOVARTIND dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.4%

$25.0 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+20.1%

0 consecutive years of growth

Total shareholder yield

+2.4%

Next ex-dividend date: 2025-07-23

Ownership

Who owns NSE/NOVARTIND?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.2%

Share of float held by funds and institutions

Insider ownership

+0.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.0%

Negative means the company is buying back shares.

Technical

NSE/NOVARTIND momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

0.0

Below 30: short-term oversold

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

0.42

Less volatile than the market

Sharpe ratio

5.53

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/NOVARTIND

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/NOVARTIND stock rating?

nse/NOVARTIND is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/NOVARTIND analysis?

The full report lives at /stocks/nse/NOVARTIND/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/NOVARTIND?

The latest report frames nse/NOVARTIND around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/NOVARTIND page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.